Showing results (231-240 of 384) with videos related to

Sort By:
Pageof 39
Oncotarget|January 12, 2013
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatmentSílvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
International Journal of Oncology|June 12, 2012
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligandsDolors Carrión-Salip, Clara Panosa, Javier A Menendez, et al.
International Journal of Oncology|November 21, 2008
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancerCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Eugeni López-Bonet, et al.
Scientific Reports|December 14, 2012
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotencyAlejandro Vazquez-Martin, Sílvia Cufi, Eugeni Lopez-Bonet, et al.
International Journal of Molecular Sciences|October 22, 2020
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast CancerAdriana Papadimitropoulou, Luciano Vellon, Ella Atlas, et al.
Journal of Reproduction and Fertility|March 1, 1988
Androgenic control of immunoreactive somatostatin in the Harderian gland of the Syrian hamsterM Puig-Domingo, J M Guerrero, R J Reiter, et al.
Applied Microbiology and Biotechnology|July 1, 1990
Production and characterization of human gamma interferon from Escherichia coliL Perez, J Vega, C Chuay, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 24, 2011
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesionsAlejandro Vazquez-Martin, Eugeni López-Bonetc, Sílvia Cufí, et al.
Aging|February 11, 2022
Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cellsIngrid Espinoza, Lin Yang, Travis Vander Steen, et al.
Journal of Innate Immunity|September 19, 2012
Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal Paneth cell α-defensinsA Menendez, B P Willing, M Montero, et al.
Pageof 39